PART 15Consequential Amendments

Amendment of the Medicines for Human Use (Clinical Trials) Regulations 200458

1

The Medicines for Human Use (Clinical Trials) Regulations 200420 are amended as follows.

2

In regulation—

a

17(2)(b)(ii) (request for authorisation to conduct a clinical trial),

b

24(10) (amendments by the sponsor),

c

38(3)(b) (application for manufacturing authorisation),

d

44(8) (variation of manufacturing authorisation),

for “Medicines (Products for Human Use) (Fees) Regulations 2012” substitute “Medicines (Products for Human Use) (Fees) Regulations 2013”.